Subsequently, we examined specific oncogenes and tumor suppressor genes with top-rank Genomic Identification of Significant Targets in Cancer (GISTIC) peaks to estimate somatic copy number alterations (CNAs) in HER2-low TNBC samples from FUSCC. The gene discussed is ERBB2; the disease is cancer.